Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis

Ardalan, Zaid S.; Sparrow, Miles; Gibson, Peter R.

(2020), GASTROENTEROLOGY, 159(1), 359-400.

DOI: 10.1053/j.gastro.2020.02.065

Systematic Review: Clinical Utility of Gastrointestinal Ultrasound in the Diagnosis, Assessment and Management of Patients With Ulcerative Colitis

Smith, Rebecca L.; Taylor, Kirstin M.; Friedman, Antony B.; Gibson, Robert N.; Gibson, Peter R.

(2020), J CROHNS COLITIS, 14(4), 465-479.

DOI: 10.1093/ecco-jcc/jjz163

Survival of patients with ruptured and non-ruptured hepatocellular carcinoma

Tan, Natassia P.; Majeed, Ammar; Roberts, Stuart K.; Gow, Paul J.; Hey, Penny; Mah, Xianjun; Goodwin, Mark; Sood, Siddharth; Lubel, John; Nicoll, Amanda; Dev, Anouk; Bell, Sally J.; Kemp, William W.

(2020), MED J AUSTRALIA, 212(6), 277-278.

DOI: 10.5694/mja2.50483

Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes

Christensen, Britt; Hanauer, Stephen B.; Gibson, Peter R.; Turner, Jerrold R.; Hart, John; Rubin, David T.

(2020), J CROHNS COLITIS, 14(10), 1345-1353.

DOI: 10.1093/ecco-jcc/jjaa068

Renin–angiotensin–aldosterone system inhibitors in CoviD-19

Lubel, John; Garg, Mayur

(2020), NEW ENGL J MED, 382(24), e92.

DOI: 10.1056/NEJMc2013707

Randomised clinical trial: transabdominal interferential electrical stimulation vs sham stimulation in women with functional constipation

Moore, Judith S.; Gibson, Peter R.; Burgell, Rebecca E.

(2020), ALIMENT PHARM THER, 51(8), 760-769.

DOI: 10.1111/apt.15642

Review article: the impact of diet on ileoanal pouch function and on the pathogenesis of pouchitis

Ardalan, Zaid S.; Yao, Chu K.; Sparrow, Miles P.; Gibson, Peter R.

(2020), ALIMENT PHARM THER, 52(8), 1323-1340

DOI: 10.1111/apt.16085

Review article: FODMAPS, prebiotics and gut health-the FODMAP hypothesis revisited

Gibson, Peter R.; Halmos, Emma P.; Muir, Jane G.

(2020), ALIMENT PHARM THER, 52(2), 233-246.

DOI: 10.1111/apt.15818

Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease

Gibson, David J.; Ward, Mark G.; Rentsch, Clarissa; Friedman, Antony B.; Taylor, Kirstin M.; Sparrow, Miles P.; Gibson, Peter R.

(2020), ALIMENT PHARM THER, 51(6), 612-628.

DOI: 10.1111/apt.15643

Practical management of inflammatory bowel disease patients during the COVID-19 pandemic

Aysha, Al Ani; Rentsch, Clarissa; Prentice, Ralley; Johnson, Doug; Bryant, Robert V.; Ward, Mark G.; Costello, Samuel P.; Lewindon, Peter; Ghaly, Simon; Connor, Susan J.; Begun, Jakob; Christensen, Britt

(2020), INTERN MED J, 50(7), 798-804.

DOI: 10.1111/imj.14889

Nutritional profile of rodent diets impacts experimental reproducibility in microbiome preclinical research

Tuck, C. J.; De Palma, G.; Takami, K.; Brant, B.; Caminero, A.; Reed, D. E.; Muir, J. G.; Gibson, P. R.; Winterborn, A.; Verdu, E. F.; Bercik, P.; Vanner, S.

(2020), SCI REP-UK, 10(1), 17784

DOI: 10.1038/s41598-020-74460-8

Multi-target Treatment for Irritable Bowel Syndrome with STW 5: Pharmacological Modes of Action

Allescher, Hans-Dieter; Burgell, Rebecca; Malfertheiner, Peter; Mearin, Fermin

(2020), J GASTROINTEST LIVER, 29(2), 227-233.

DOI: 10.15403/jgld-814

Implementation of the low FODMAP diet in functional gastrointestinal symptoms

Tuck, Caroline J.; Reed, David E.; Muir, Jane G.; Vanner, Stephen J.

(2020), NEUROGASTROENT MOTIL, 32(1), e13730.

DOI: 10.1111/nmo.13730

Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing

Christensen, Britt; Erlich, Jonathan; Gibson, Peter R.; Turner, Jerrold R.; Hart, John; Rubin, David T.

(2020), CLIN GASTROENTEROL H, 18(11), 2518-2525.e1

DOI: 10.1016/j.cgh.2019.11.056

Gastrointestinal ACE2, COVID-19 and IBD

Garg, Mayur; Christensen, Britt; Lubel, John S.

(2020), GASTROENTEROLOGY, 159(4), 1623-1624.

DOI: 10.1053/j.gastro.2020.04.051

Editorial: inaccuracies in attribution of symptoms due to gluten—not just in those with self-reported noncoeliac gluten sensitivity

Gibson, Peter R.

(2020), ALIMENT PHARM THER, 51(3), 402-403.

DOI: 10.1111/apt.15620

Prebiotics Versus Low FODMAP Diet

Varney, Jane; Muir, Jane G.; Gibson, Peter R.

(2019), GASTROENTEROLOGY, 156(4), 1222

DOI: 10.1053/j.gastro.2018.10.060

Efficacy of glutamine in postinfection IBS

Ford, Alexander Charles; Gibson, Peter R.

(2019), GUT, 68(10), 1905-1906.

DOI: 10.1136/gutjnl-2018-317438

Reply

Colombel, Jean Frederic; Shin, Andrea; Gibson, Peter R.

(2019), CLIN GASTROENTEROL H, 17(3), 573-574.

DOI: 10.1016/j.cgh.2018.08.073

Letters: low FODMAP diet—directions for future research and the low FODMAP diet is not the only diet for IBS—authors' reply

Mitchell, Hannah; Porter, Judi; Gibson, Peter R.; Barrett, Jacqueline; Garg, Mayur

(2019), ALIMENT PHARM THER, 49(8), 1109-1110.

DOI: 10.1111/apt.15199

4 5 6 7 8